🇺🇸 FDA
Pipeline program

Placebo for ponsegromab (PF-06946860) solution for injection, Ponsegromab (PF-06946860)

C3651003

Phase 2 small_molecule active

Quick answer

Placebo for ponsegromab (PF-06946860) solution for injection, Ponsegromab (PF-06946860) for Cancer cachexia is a Phase 2 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
Cancer cachexia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials